Maverick Capital’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-29,594
Closed -$1.95M 248
2024
Q3
$1.95M Buy
+29,594
New +$1.95M 0.04% 125
2024
Q1
Sell
-2,977
Closed -$227K 452
2023
Q4
$227K Sell
2,977
-2,331
-44% -$178K ﹤0.01% 319
2023
Q3
$368K Buy
5,308
+990
+23% +$68.6K 0.01% 201
2023
Q2
$407K Sell
4,318
-2,815
-39% -$266K 0.01% 279
2023
Q1
$590K Buy
7,133
+3,511
+97% +$290K 0.01% 210
2022
Q4
$270K Sell
3,622
-10,616
-75% -$792K 0.01% 311
2022
Q3
$1.18M Buy
+14,238
New +$1.18M 0.03% 126
2020
Q4
Sell
-15,652
Closed -$1.25M 710
2020
Q3
$1.25M Sell
15,652
-14,889
-49% -$1.19M 0.02% 223
2020
Q2
$2.11M Buy
+30,541
New +$2.11M 0.04% 169
2018
Q4
Sell
-117,480
Closed -$6.82M 272
2018
Q3
$6.82M Sell
117,480
-188,040
-62% -$10.9M 0.08% 130
2018
Q2
$14.8M Buy
305,520
+81,090
+36% +$3.93M 0.17% 61
2018
Q1
$10.4M Sell
224,430
-13,950
-6% -$649K 0.13% 93
2017
Q4
$8.96M Buy
238,380
+100,710
+73% +$3.78M 0.11% 66
2017
Q3
$5.02M Buy
137,670
+36,630
+36% +$1.33M 0.06% 76
2017
Q2
$3.98M Buy
101,040
+8,370
+9% +$330K 0.05% 64
2017
Q1
$2.91M Sell
92,670
-22,650
-20% -$710K 0.04% 49
2016
Q4
$3.6M Buy
115,320
+34,620
+43% +$1.08M 0.05% 34
2016
Q3
$3.24M Sell
80,700
-16,200
-17% -$651K 0.04% 48
2016
Q2
$3.22M Buy
+96,900
New +$3.22M 0.04% 43
2015
Q3
Sell
-11,760
Closed -$279K 123
2015
Q2
$279K Hold
11,760
﹤0.01% 64
2015
Q1
$279K Buy
+11,760
New +$279K ﹤0.01% 67